Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001389413 | SCV001590761 | pathogenic | Cortical dysplasia-focal epilepsy syndrome | 2020-07-21 | criteria provided, single submitter | clinical testing | This variant is an out-of-frame deletion of the genomic region encompassing exon 4 of the CNTNAP2 gene. This creates a premature translational stop signal and is expected to result in an absent or disrupted protein product. This variant has not been reported in the literature in individuals with CNTNAP2-related disease. Loss-of-function variants in CNTNAP2 are known to be pathogenic (PMID: 19896112, 25045150, 26843181). For these reasons, this variant has been classified as Pathogenic. |